Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-15-209050
Filing Date
2015-06-01
Accepted
2015-06-01 16:14:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d937605dsc13da.htm SC 13D/A 27212
  Complete submission text file 0001193125-15-209050.txt   28824
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filed by) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11119 NORTH TORREY PINES ROAD, SUITE 50 SAN DIEGO CA 92037
Business Address 11119 NORTH TORREY PINES ROAD, SUITE 50 SAN DIEGO CA 92037 858-550-7810
Viking Therapeutics, Inc. (Subject) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88828 | Film No.: 15903548
SIC: 2834 Pharmaceutical Preparations